J&J One-Shot Covid Vaccine Expects to Get FDA’s Approval for Emergency Use on Friday!
FDA’s staff endorsed J&J’s single-shot Covid-19 vaccine for emergency use as the jab showed positive results in moderate and severe cases. 
FDA’s staff endorsed J&J’s single-shot Covid-19 vaccine for emergency use as the jab showed positive results in moderate and severe cases.
25 ก.พ. 2564

The Food and Drug Administration (FDA)’s staff endorsed Johnson &amp; Johnson (J&amp;J)’s Covid-19 vaccine for emergency use as the jab showed positive results in moderate and severe cases.
 
J&amp;J’s vaccine showed 86% efficacy against severe forms of Covid-19 in the United States, and 82% against severe variants in South Africa.
FDA’s Vaccines and Related Biological Products Advisory Committee will meet on Friday to review J&amp;J’s request for emergency use of its vaccine.
 
More importantly, J&amp;J’s vaccine requires only one dose, making logistics much easier as well as more convenient for the patients.